Intraventricular Cerliponase Alfa Treatment in a Patient with Advanced Neuronal Ceroid Lipofuscinosis Type 2. [PDF]
Nakashima S +9 more
europepmc +1 more source
Akap5 links synaptic dysfunction to neuroinflammatory signaling in a mouse model of infantile neuronal ceroid lipofuscinosis. [PDF]
Koster KP +8 more
europepmc +1 more source
Recognizing Lipofuscinosis as a Guide in Antiepileptic Treatment: Clinical Description of the First Mexican Case With Neuronal Ceroid Lipofuscinosis Type 7 (NCL7). [PDF]
Kimball TN +4 more
europepmc +1 more source
The neuronal ceroid lipofuscinosis type 2 - associated variants: An analysis of alterations in the <i>TPP1</i> gene and genotype-phenotype correlation in Ukraine. [PDF]
Olkhovych N +11 more
europepmc +1 more source
TPP1 Variants in Iranian patients: A Novel Pathogenic Homozygous Variant Causing Neuronal Ceroid Lipofuscinosis 2. [PDF]
Vafaei N +10 more
europepmc +1 more source
Classic and Atypical Late Infantile Neuronal Ceroid Lipofuscinosis in Latin America: Clinical and Genetic Aspects, and Treatment Outcome with Cerliponase Alfa. [PDF]
Guelbert N +34 more
europepmc +1 more source
This study sought to genetically define the first family diagnosed with neuronal ceroid lipofuscinosis from Qatar. Onset was in late infancy (3 years), and sequencing in the affected children revealed a novel homozygous c.613C>T change in exon 3 of ...
Tawfeg Ben-Omran +2 more
exaly +2 more sources

